Some types of cancer remain resistant to chemotherapy treatments. Researchers at our laboratory [Collaboration with Inserm, CNRS, Sorbonne University, PSL University, Univ. Grenoble Alpes, CEA and ESRF] have studied the properties and mechanism of action of a new organometallic anti-tumoral molecule.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.